These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Moisset PA, Skuk D, Asselin I, Goulet M, Roy B, Karpati G, Tremblay JP. Biochem Biophys Res Commun; 1998 Jun 09; 247(1):94-9. PubMed ID: 9636661 [Abstract] [Full Text] [Related]
10. A method to codetect introduced genes and their products in gene therapy protocols. Gussoni E, Wang Y, Fraefel C, Miller RG, Blau HM, Geller AI, Kunkel LM. Nat Biotechnol; 1996 Aug 09; 14(8):1012-6. PubMed ID: 9631042 [Abstract] [Full Text] [Related]
11. Systemic administration of PRO051 in Duchenne's muscular dystrophy. Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC. N Engl J Med; 2011 Apr 21; 364(16):1513-22. PubMed ID: 21428760 [Abstract] [Full Text] [Related]
12. Myoblast transfer therapy for Duchenne muscular dystrophy. Law PK, Goodwin TG, Fang QW, Chen M, Li HJ, Florendo JA, Kirby DS. Acta Paediatr Jpn; 1991 Apr 21; 33(2):206-15. PubMed ID: 1957647 [Abstract] [Full Text] [Related]
15. Gene complementation using myoblast transfer into fetal muscle. Sopper MM, Hauschka SD, Hoffman E, Ontell M. Gene Ther; 1994 Mar 21; 1(2):108-13. PubMed ID: 7584065 [Abstract] [Full Text] [Related]